301089.SZ Stock Analysis
30
Uncovered
Xinxiang Tuoxin Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Xinxiang Tuoxin Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical synthetic biological fermented nucleoside APIs and pharmaceutical intermediates. The company is headquartered in Xinxiang, Henan and currently employs 1,371 full-time employees. The company went IPO on 2021-10-27. The firm's main business is the research, development, production and sales of chemical synthesis, bio-fermentation nucleoside (acid) active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The firm's products include citicoline sodium, ribavirin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine and other APIs and pharmaceutical intermediates. The firm's products are mainly used in the fields of antiviral, antitumor and nervous system medications.